Coronary disease & ACS

Diagnostic accuracy of late gadolinium enhancement cardiac MRI for coronary artery disease in patients with reduced left ventricular ejection fraction

HeartPublished prospective, multicentre cohort study

Authors' conclusion

In this large, prospective multicentre study with independent image review, rest LGE-CMR demonstrated limited sensitivity for detecting significant CAD in patients with rLVEF. Relying solely on CMR could lead to missed diagnoses and undertreatment. CMR should be integrated with other diagnostic tools to optimise care in this population.

Study context

Population
Adults with new-onset reduced left ventricular ejection fraction (rLVEF)≤45% without obvious cause, undergoing rest cardiac MRI (CMR) and coronary angiographymedian age 63 years, 68% male
Participants
380 adults
Exposure
Rest LGE-CMR against coronary angiography for detecting significant coronary artery disease (CAD)
Outcome
Sensitivity of CMR in detecting significant CAD
Methodological details10 centres, independent, blinded image review
  • 10 centres
  • Independent, blinded image review

Main finding

As reported in the abstract

Sensitivity (95% CI: 43% to 71%)

57%

Observational data: associations, not effects.

Further findings

Prevalence of significant CAD

Significant CAD present
49 (13%)

Ischaemic scars on CMR

CMR identified ischaemic scars
106 (28%)

Other diagnostic performance of CMR

Specificity (95% CI: 72% to 81%)
76%
Positive predictive value (95% CI: 18% to 35%)
26%
Negative predictive value (95% CI: 89% to 95%)
92%

Missed significant CAD with a CMR-first strategy

Significant CAD cases missed
43%
Of missed cases, requiring revascularisation
86%

Original publication

Diagnostic accuracy of late gadolinium enhancement cardiac MRI for coronary artery disease in patients with reduced left ventricular ejection fraction. Heart. Published 27 March 2025. doi:10.1136/heartjnl-2024-325419

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.